The Industrial Boiler Market is witnessing strong growth driven by rising demand from power generation, chemicals, and food industries. Key players l ...

Sun Pharma share price declined more than 4% on Friday after the drug major reported its Q4 results. Sun Pharma shares fell as much as 4.86% to ₹1,636.30 apiece on the BSE. The company’s ...

With the goal to become a top 3 pharma company in China, Novartis has been busy tapping into the expertise of local drugmakers. In its latest collaboration, Novartis has signed a strategic ...

Sun Pharmaceuticals share price today, May 23: The share price of Sun Pharmaceuticals has fallen over 4% in the last five trading sessions. (Image: Freepik) Sun Pharmaceuticals’ share price fell ...

Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe psoriasis and atopic dermatitis, as they did not meet the primary endpoints.

A little less than a year after cutting the ribbon at a new glass syringe factory in Hungary, Schott Pharma is making good on its pledge to swiftly expand the site. Schott—which produces glass ...

The Centre’s Department of Pharmaceuticals is inviting applications from drugmakers for a production linked incentive (PLI) scheme to encourage setting up new manufacturing capacities for as ...

The move raised concerns that profits of firms across the supply chain would be squeezed, triggering a rout in pharmaceutical stocks on Monday. Innovent Biologics, an industry bellwether based in ...

The pool of attendees typically includes leading medical researchers, pharmaceutical company executives and patient advocates. The annual megaconference is known for attracting a diverse audience of ...

There's little doubt these pharmaceutical companies' costs will soon be rising at least a little. The tariff war the U.S. is waging against most of the world stabilized somewhat earlier this month.

OneSource Specialty Pharma, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹2109.35. The stock has experienced fluctuations today ...

SAN DIEGO - aTyr Pharma, Inc. (NASDAQ:ATYR), a clinical stage biotechnology company with a market capitalization of $480 million, announced positive interim results from a Phase 2 study of its ...